MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted… Sep 27, 2021
MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey Centers Sep 23, 2021
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr.… Sep 22, 2021
Small Pharma Successfully Completes Phase I Clinical Trial of DMT in Combination with Supportive Psychotherapy Sep 21, 2021
Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and Improved Safety Profile for its… Sep 20, 2021
Delic to Acquire Ketamine Wellness Centers Inc, Becoming Largest Psychedelic Wellness Chain in United States Sep 20, 2021
